Vir Biotechnology, Inc. (VIR)

United States Steel Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	273.57	222.95	241.58	848.63	347.82	436.58
Short-Term Investments	528.09	682.4	1,281	1,553	360.33	300.29
Cash & Short-Term Investments	801.66	905.35	1,522	2,402	708.15	736.86
Cash Growth	-30.28%	-40.53%	-36.62%	239.20%	-3.90%	92.17%
Accounts Receivable	-	-	-	-	773.08	-
Other Receivables	5.4	5.1	11.6	28.9	-	1.9
Receivables	5.4	5.1	11.6	28.9	773.08	1.9
Prepaid Expenses	36.99	42.63	40.95	57.84	73	25.61
Restricted Cash	88.15	89.39	13.27	12.68	8.59	7.99
Other Current Assets	-	-	-	17.62	-	-
Total Current Assets	932.21	1,042	1,588	2,519	1,563	772.37
Property, Plant & Equipment	120.24	122.86	167.2	188.17	130.05	79.89
Long-Term Investments	218.14	190.02	105.28	23.93	201.39	-
Goodwill	16.94	16.94	16.94	16.94	16.94	16.94
Other Intangible Assets	8.07	8.12	22.57	32.76	33.29	33.82
Other Long-Term Assets	12.13	18.42	18.86	21.23	9.78	15.75
Total Assets	1,308	1,399	1,919	2,802	1,954	918.76
Accounts Payable	3.73	5.08	6.33	6.42	6.52	5.08
Accrued Expenses	85.02	66.53	82.15	462.07	129.54	69.84
Current Portion of Leases	7.93	7.75	12.87	4.14	3.93	3.63
Current Income Taxes Payable	-	-	-	15.23	6.22	-
Current Unearned Revenue	11.94	12.65	64.85	15.52	98.21	6.45
Other Current Liabilities	28.68	27.65	9.2	7.65	96.83	14.07
Total Current Liabilities	137.29	119.66	175.41	511.03	341.24	99.06
Long-Term Leases	88.17	90.14	111.67	123.84	133.56	66.56
Long-Term Unearned Revenue	-	-	-	53.21	3.82	3.82
Long-Term Deferred Tax Liabilities	-	-	-	-	18.44	3.25
Other Long-Term Liabilities	38.45	38.63	41.74	36.05	25.36	29.22
Total Liabilities	263.91	248.43	328.82	724.13	522.42	201.91
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,927	1,912	1,829	1,710	1,572	1,385
Retained Earnings	-880.75	-759.78	-237.82	377.24	-138.6	-667.18
Comprehensive Income & Other	-1.98	-1.72	-0.82	-9.12	-1.1	-1.28
Total Common Equity	1,044	1,150	1,590	2,078	1,432	716.85
Shareholders' Equity	1,044	1,150	1,590	2,078	1,432	716.85
Total Liabilities & Equity	1,308	1,399	1,919	2,802	1,954	918.76
Total Debt	96.1	97.89	124.54	127.97	137.49	70.18
Net Cash (Debt)	705.57	807.46	1,398	2,274	570.66	666.68
Net Cash Growth	-31.41%	-42.24%	-38.53%	298.50%	-14.40%	73.98%
Net Cash Per Share	5.16	5.93	10.42	16.87	4.28	5.59
Filing Date Shares Outstanding	138.24	137.14	135.03	133.53	132.3	127.84
Total Common Shares Outstanding	138.06	136.96	134.78	133.24	131.16	127.42
Working Capital	794.92	922.8	1,413	2,008	1,222	673.3
Book Value Per Share	7.56	8.40	11.80	15.60	10.92	5.63
Tangible Book Value	1,019	1,125	1,551	2,028	1,382	666.1
Tangible Book Value Per Share	7.38	8.22	11.51	15.22	10.53	5.23
Machinery	44.76	44.9	49.4	41.93	22.57	18.77
Construction In Progress	1.81	1.07	0.23	-	26.93	1.14
Leasehold Improvements	53.98	53.99	80.29	84.42	7.83	7.27

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q